Effects of -Cryptoxanthin on Improvement in Osteoporosis Risk: A Systematic Review and Meta-Analysis of Observational Studies

Overview

Journal Foods

Specialty Biotechnology

Date 2021 Feb 5

PMID 33540706

Citations 5

Authors

Sun Jo Kim

Nguyen Hoang Anh

Nguyen Co Diem

Seongoh Park

Young Hyun Cho

Nguyen Phuoc Long

In Guk Hwang

Johan Lim

Sung Won Kwon

Affiliations

Soon will be listed here.

Abstract

Many studies have analyzed the effects of -cryptoxanthin (BCX) on osteoporosis and bone health. This systematic review and meta-analysis aimed at providing quantitative evidence for the effects of BCX on osteoporosis. Publications were selected and retrieved from three databases and carefully screened to evaluate their eligibility. Data from the final 15 eligible studies were extracted and uniformly summarized. Among the 15 studies, seven including 100,496 individuals provided information for the meta-analysis. A random effects model was applied to integrate the odds ratio (OR) to compare the risk of osteoporosis and osteoporosis-related complications between the groups with high and low intake of BCX. A high intake of BCX was significantly correlated with a reduced risk of osteoporosis (OR = 0.79, 95% confidence interval (CI) 0.70-0.90, = 0.0002). The results remained significant when patients were stratified into male and female subgroups as well as Western and Asian cohorts. A high intake of BCX was also negatively associated with the incidence of hip fracture (OR = 0.71, 95% CI 0.54-0.94, = 0.02). The results indicate that BCX intake potentially reduces the risk of osteoporosis and hip fracture. Further longitudinal studies are needed to validate the causality of current findings.

Citing Articles

Lutein Maintains Bone Mass In Vitro and In Vivo Against Disuse-Induced Bone Loss in Hindlimb-Unloaded Mice.

Tanaka Y, Tominari T, Takatoya M, Arai D, Sugasaki M, Ichimaru R Nutrients. 2025; 16(24.

PMID: 39770893 PMC: 11678298. DOI: 10.3390/nu16244271.

Nutraceuticals and Functional Foods: A Comprehensive Review of Their Role in Bone Health.

Faienza M, Giardinelli S, Annicchiarico A, Chiarito M, Barile B, Corbo F Int J Mol Sci. 2024; 25(11).

PMID: 38892062 PMC: 11172758. DOI: 10.3390/ijms25115873.

Plasma metabolomics signatures of developmental dysplasia of the hip in Tibet plateau.

Guo Y, Li X, Yang D, Yedron N, Chen T, Li J Orphanet J Rare Dis. 2024; 19(1):228.

PMID: 38851765 PMC: 11161931. DOI: 10.1186/s13023-024-03230-w.

A molecular index for biological age identified from the metabolome and senescence-associated secretome in humans.

Hamsanathan S, Anthonymuthu T, Prosser D, Lokshin A, Greenspan S, Resnick N Aging Cell. 2024; 23(4):e14104.

PMID: 38454639 PMC: 11019119. DOI: 10.1111/acel.14104.

Comprehensive Update on Carotenoid Colorants from Plants and Microalgae: Challenges and Advances from Research Laboratories to Industry.

Rodriguez-Amaya D, Esquivel P, Melendez-Martinez A Foods. 2023; 12(22).

PMID: 38002140 PMC: 10670565. DOI: 10.3390/foods12224080.

References

Diep T, Pook C, Rush E, Yoo M . Quantification of Carotenoids, α-Tocopherol, and Ascorbic Acid in Amber, Mulligan, and Laird's Large Cultivars of New Zealand Tamarillos ( Cav.). Foods. 2020; 9(6). PMC: 7353566. DOI: 10.3390/foods9060769. View

Tucker K . Vegetarian diets and bone status. Am J Clin Nutr. 2014; 100 Suppl 1:329S-35S. DOI: 10.3945/ajcn.113.071621. View

Lim D, Lee Y, Kim Y . Preventive effects of Citrus unshiu peel extracts on bone and lipid metabolism in OVX rats. Molecules. 2014; 19(1):783-94. PMC: 6271111. DOI: 10.3390/molecules19010783. View

Dai Z, Wang R, Ang L, Low Y, Yuan J, Koh W . Protective effects of dietary carotenoids on risk of hip fracture in men: the Singapore Chinese Health Study. J Bone Miner Res. 2013; 29(2):408-17. PMC: 3894263. DOI: 10.1002/jbmr.2041. View

Sahin K, Orhan C, Akdemir F, Tuzcu M, Sahin N, Yilmaz I . β-Cryptoxanthin ameliorates metabolic risk factors by regulating NF-κB and Nrf2 pathways in insulin resistance induced by high-fat diet in rodents. Food Chem Toxicol. 2017; 107(Pt A):270-279. DOI: 10.1016/j.fct.2017.07.008. View

Finkelstein J, Lee M, Sowers M, Ettinger B, Neer R, Kelsey J . Ethnic variation in bone density in premenopausal and early perimenopausal women: effects of anthropometric and lifestyle factors. J Clin Endocrinol Metab. 2002; 87(7):3057-67. DOI: 10.1210/jcem.87.7.8654. View

Sugiura M, Nakamura M, Ogawa K, Ikoma Y, Ando F, Yano M . Bone mineral density in post-menopausal female subjects is associated with serum antioxidant carotenoids. Osteoporos Int. 2007; 19(2):211-9. DOI: 10.1007/s00198-007-0457-2. View

Sahni S, Hannan M, Blumberg J, Cupples L, Kiel D, Tucker K . Inverse association of carotenoid intakes with 4-y change in bone mineral density in elderly men and women: the Framingham Osteoporosis Study. Am J Clin Nutr. 2008; 89(1):416-24. PMC: 3151434. DOI: 10.3945/ajcn.2008.26388. View

Denova-Gutierrez E, Mendez-Sanchez L, Munoz-Aguirre P, Tucker K, Clark P . Dietary Patterns, Bone Mineral Density, and Risk of Fractures: A Systematic Review and Meta-Analysis. Nutrients. 2018; 10(12). PMC: 6316557. DOI: 10.3390/nu10121922. View

10.

Malmir H, Shab-Bidar S, Djafarian K . Vitamin C intake in relation to bone mineral density and risk of hip fracture and osteoporosis: a systematic review and meta-analysis of observational studies. Br J Nutr. 2018; 119(8):847-858. DOI: 10.1017/S0007114518000430. View

11.

Stransky M, Rysava L . Nutrition as prevention and treatment of osteoporosis. Physiol Res. 2009; 58 Suppl 1:S7-S11. DOI: 10.33549/physiolres.931858. View

12.

Cohen K, Liu Y, Luo J, Appleton C, Colditz G . Plasma carotenoids and the risk of premalignant breast disease in women aged 50 and younger: a nested case-control study. Breast Cancer Res Treat. 2017; 162(3):571-580. PMC: 5341742. DOI: 10.1007/s10549-017-4152-5. View

13.

Shen C, Von Bergen V, Chyu M, Jenkins M, Mo H, Chen C . Fruits and dietary phytochemicals in bone protection. Nutr Res. 2012; 32(12):897-910. DOI: 10.1016/j.nutres.2012.09.018. View

14.

Xu J, Song C, Song X, Zhang X, Li X . Carotenoids and risk of fracture: a meta-analysis of observational studies. Oncotarget. 2016; 8(2):2391-2399. PMC: 5356809. DOI: 10.18632/oncotarget.13678. View

15.

Hirata N, Ichimaru R, Tominari T, Matsumoto C, Watanabe K, Taniguchi K . Beta-Cryptoxanthin Inhibits Lipopolysaccharide-Induced Osteoclast Differentiation and Bone Resorption via the Suppression of Inhibitor of NF-κB Kinase Activity. Nutrients. 2019; 11(2). PMC: 6412436. DOI: 10.3390/nu11020368. View

16.

Barrett-Connor E, Siris E, Wehren L, Miller P, Abbott T, Berger M . Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res. 2005; 20(2):185-94. DOI: 10.1359/JBMR.041007. View

17.

Redmond J, Jarjou L, Zhou B, Prentice A, Schoenmakers I . Ethnic differences in calcium, phosphate and bone metabolism. Proc Nutr Soc. 2014; 73(2):340-51. PMC: 3981475. DOI: 10.1017/S0029665114000068. View

18.

Zhang Z, Cao W, Liu J, Cao Y, Su Y, Chen Y . Greater serum carotenoid concentration associated with higher bone mineral density in Chinese adults. Osteoporos Int. 2016; 27(4):1593-1601. DOI: 10.1007/s00198-015-3425-2. View

19.

Burri B, La Frano M, Zhu C . Absorption, metabolism, and functions of β-cryptoxanthin. Nutr Rev. 2016; 74(2):69-82. PMC: 4892306. DOI: 10.1093/nutrit/nuv064. View

20.

Yamaguchi M . Role of carotenoid β-cryptoxanthin in bone homeostasis. J Biomed Sci. 2012; 19:36. PMC: 3361488. DOI: 10.1186/1423-0127-19-36. View